ALC-0159

ALC-0159

ALC-0159 is a PEG lipid molecule (i.e. PEGylated lipid), It is the N,N-dimyristylamide of 2-hydroxyacetic acid, O-pegylated to a PEG chain mass of about 2 kilodaltons (corresponding to about 45-46 ethylene oxide units per molecule of N,N-dimyristyl hydroxyacetamide). ALC-0159 is a non-ionic surfactant by its nature and It has been deployed in the Pfizer-BioNTech SARS-CoV-2 mRNA vaccine that contains the active ingredient tozinameran. Reagent grade, for research use only.

Molecular structure of the compound BP-25711
    • Unit
    • Price
    • Qty
    • 50 MG
    • $240.00
    • 100 MG
    • $430.00
    • 250 MG
    • $650.00
    • 500 MG
    • $980.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Jalil, S., Keskinen, T., Juutila, J., Maldonado, R. S., Euro, L., Suomalainen, A., ... & Wartiovaara, K. (2024). Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors. The American Journal of Human Genetics, 111(4), 714-728.
    https://www.cell.com/ajhg/fulltext/S0002-9297(24)00077-6
  2. Lewis, M. M., Soto, M. R., Maier, E. Y., Wulfe, S. D., Bakheet, S., Obregon, H., & Ghosh, D. (2023). Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles. Bioengineering & Translational Medicine, e10580.
    https://aiche.onlinelibrary.wiley.com/doi/full/10.1002/btm2.10580
  3. McMillan, C., Druschitz, A., Rumbelow, S., Borah, A., Binici, B., Rattray, Z., & Perrie, Y. (2024). Tailoring lipid nanoparticle dimensions through manufacturing processes. RSC pharmaceutics.
    https://pubs.rsc.org/en/content/articlehtml/2024/pm/d4pm00128a